Pulse lineResearch With Heart Logo

ARIC Publications

Filters: Keyword is Neuropsychological Tests  [Clear All Filters]
2005
Blair CK, Folsom AR, Knopman DS, Bray MS, Mosley TH, Boerwinkle E. "APOE genotype and cognitive decline in a middle-aged cohort." Neurology. 2005;64(2):268-76.
Mosley TH, Knopman DS, Catellier DJ, et al. "Cerebral MRI findings and cognitive functioning: the Atherosclerosis Risk in Communities study." Neurology. 2005;64(12):2056-62.
2007
Beydoun MA, Kaufman JS, Satia JA, Rosamond W, Folsom AR. "Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study." Am J Clin Nutr. 2007;85(4):1103-11.
2009
Knopman DS, Mosley TH, Catellier DJ, Coker LH. "Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study." Alzheimers Dement. 2009;5(3):207-14.
Lesage SR, Mosley TH, Wong TY, et al. "Retinal microvascular abnormalities and cognitive decline: the ARIC 14-year follow-up study." Neurology. 2009;73(11):862-8.
2010
Rose KM, Couper D, Eigenbrodt ML, Mosley TH, A Sharrett R, Gottesman RF. "Orthostatic hypotension and cognitive function: the Atherosclerosis Risk in Communities Study." Neuroepidemiology. 2010;34(1):1-7.
2013
Bressler J, Fornage M, Demerath EW, et al. "Fat mass and obesity gene and cognitive decline: the Atherosclerosis Risk in Communities Study." Neurology. 2013;80(1):92-9.
2014
Gottesman RF, Rawlings AM, Sharrett ARichey, et al. "Impact of differential attrition on the association of education with cognitive change over 20 years of follow-up: the ARIC neurocognitive study." Am J Epidemiol. 2014;179(8):956-66.
Gottesman RF, Schneider ALC, Albert M, et al. "Midlife hypertension and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive study." JAMA Neurol. 2014;71(10):1218-27.
Mayeda ER, Haan MN, Neuhaus J, et al. "Type 2 diabetes and cognitive decline over 14 years in middle-aged African Americans and whites: the ARIC Brain MRI Study." Neuroepidemiology. 2014;43(3-4):220-7.
Schneider ALC, Lutsey PL, Alonso A, et al. "Vitamin D and cognitive function and dementia risk in a biracial cohort: the ARIC Brain MRI Study." Eur J Neurol. 2014;21(9):1211-8, e69-70.
2016
Rawlings AM, Bandeen-Roche K, Gross AL, et al. "Factor structure of the ARIC-NCS Neuropsychological Battery: An evaluation of invariance across vascular factors and demographic characteristics." Psychol Assess. 2016;28(12):1674-1683.
Schneider ALC, Jonassaint C, Sharrett ARichey, et al. "Hemoglobin, Anemia, and Cognitive Function: The Atherosclerosis Risk in Communities Study." J Gerontol A Biol Sci Med Sci. 2016;71(6):772-9.
Hill WD, Davies G, Harris SE, et al. "Molecular genetic aetiology of general cognitive function is enriched in evolutionarily conserved regions." Transl Psychiatry. 2016;6(12):e980.
2017
Kim SM, Zhao D, Schneider ALC, et al. "Association of parathyroid hormone with 20-year cognitive decline: The ARIC study." Neurology. 2017;89(9):918-926.
Bancks MP, Alonso A, Gottesman RF, Mosley TH, Selvin E. "Brain function and structure and risk for incident diabetes: The Atherosclerosis Risk in Communities Study." Alzheimers Dement. 2017;13(12):1345-1354.
Alonso A, Knopman DS, Gottesman RF, et al. "Correlates of Dementia and Mild Cognitive Impairment in Patients With Atrial Fibrillation: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS)." J Am Heart Assoc. 2017;6(7).
Bressler J, Mosley TH, Penman A, et al. "Genetic variants associated with risk of Alzheimer's disease contribute to cognitive change in midlife: The Atherosclerosis Risk in Communities Study." Am J Med Genet B Neuropsychiatr Genet. 2017;174(3):269-282.
Bressler J, Knopman DS, Sharrett ARichey, et al. "Incident Heart Failure and Cognitive Decline: The Atherosclerosis Risk in Communities Study." J Card Fail. 2017;23(1):47-55.
Dearborn JL, Zhang Y, Qiao Y, et al. "Intracranial atherosclerosis and dementia: The Atherosclerosis Risk in Communities (ARIC) Study." Neurology. 2017;88(16):1556-1563.
Bressler J, Yu B, Mosley TH, et al. "Metabolomics and cognition in African American adults in midlife: the atherosclerosis risk in communities study." Transl Psychiatry. 2017;7(7):e1173.
2018
Power MC, Rawlings A, Sharrett ARichey, et al. "Association of midlife lipids with 20-year cognitive change: A cohort study." Alzheimers Dement. 2018;14(2):167-177.
Rawlings AM, Juraschek SP, Heiss G, et al. "Association of orthostatic hypotension with incident dementia, stroke, and cognitive decline." Neurology. 2018;91(8):e759-e768.
Witt LS, Rotter J, Stearns SC, et al. "Heart Failure and Cognitive Impairment in the Atherosclerosis Risk in Communities (ARIC) Study." J Gen Intern Med. 2018;33(10):1721-1728.
Yano Y, Griswold M, Wang W, et al. "Long-Term Blood Pressure Level and Variability From Midlife to Later Life and Subsequent Cognitive Change: The ARIC Neurocognitive Study." J Am Heart Assoc. 2018;7(15):e009578.
Palta P, Chen H, Deal JA, et al. "Olfactory function and neurocognitive outcomes in old age: The Atherosclerosis Risk in Communities Neurocognitive Study." Alzheimers Dement. 2018;14(8):1015-1021.
West NA, Tingle JV, Simino J, Selvin E, Bressler J. "The PPARG Pro12Ala Polymorphism and 20-year Cognitive Decline: Race and Sex Heterogeneity." Alzheimer Dis Assoc Disord. 2018;32(2):131-136.
Deal JA, Sharrett ARichey, Rawlings AM, et al. "Retinal signs and 20-year cognitive decline in the Atherosclerosis Risk in Communities Study." Neurology. 2018;90(13):e1158-e1166.
Schneider ALC, Zhao D, Lutsey PL, et al. "Serum Vitamin D Concentrations and Cognitive Change Over 20 Years: The Atherosclerosis Risk in Communities Neurocognitive Study." Neuroepidemiology. 2018;51(3-4):131-137.
Lee AK, Rawlings AM, Lee CJ, et al. "Severe hypoglycaemia, mild cognitive impairment, dementia and brain volumes in older adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) cohort study." Diabetologia. 2018;61(9):1956-1965.